Article thumbnail

Effects of p-Synephrine alone and in Combination with Selected Bioflavonoids on Resting Metabolism, Blood Pressure, Heart Rate and Self-Reported Mood Changes

By Sidney J. Stohs, Harry G Preuss, Samuel C. Keith, Patti L. Keith, Howard Miller and Gilbert R. Kaats

Abstract

Bitter orange (Citrus aurantium) extract is widely used in dietary supplements for weight management and sports performance. Its primary protoalkaloid is p-synephrine. Most studies involving bitter orange extract and p-synephrine have used products with multiple ingredients. The current study assessed the thermogenic effects of p-synephrine alone and in conjunction with the flavonoids naringin and hesperidin in a double-blinded, randomized, placebo-controlled protocol with 10 subjects per treatment group. Resting metabolic rates (RMR), blood pressure, heart rates and a self-reported rating scale were determined at baseline and 75 min after oral ingestion of the test products in V-8 juice. A decrease of 30 kcal occurred in the placebo control relative to baseline. The group receiving p-synephrine (50 mg) alone exhibited a 65 kcal increase in RMR as compared to the placebo group. The consumption of 600 mg naringin with 50 mg p-synephrine resulted in a 129 kcal increase in RMR relative to the placebo group. In the group receiving 100 mg hesperidin in addition to the 50 mg p-synephrine plus 600 mg naringin, the RMR increased by 183 kcal, an increase that was statistically significant with respect to the placebo control (p<0.02). However, consuming 1000 mg hesperidin with 50 mg p-synephrine plus 600 mg naringin resulted in a RMR that was only 79 kcal greater than the placebo group. None of the treatment groups exhibited changes in heart rate or blood pressure relative to the control group, nor there were no differences in self-reported ratings of 10 symptoms between the treatment groups and the control group. This unusual finding of a thermogenic combination of ingredients that elevated metabolic rates without corresponding elevations in blood pressure and heart-rates warrants longer term studies to assess its value as a weight control agent

Topics: Research Paper
Publisher: Ivyspring International Publisher
OAI identifier: oai:pubmedcentral.nih.gov:3085176
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). 3-Adrenoceptor agonists: potential, pitfalls and progress.
  2. (2007). A review of the safety and efficacy of Citrus aurantium in weight management.
  3. (2010). Absorption, conjugation and excretion of the flavonones, naringenin and hesperetin from alpha-rhamnosidase-treated orange juice in human subjects.
  4. (2004). Assessment of the adverse event reports associated with Citrus aurantium (bitter orange) from
  5. (2003). Bioavailability in humans of the flavanones hesperidin and naringin after the ingestion of two doses of orange juice.
  6. (2006). Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double blind, crossover
  7. (2006). Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obesity Rev.
  8. (2004). Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exptl Biol Med.
  9. (2009). Comparative effectiveness research (CER): opportunities and challenges for the nutrition industry.
  10. (2004). Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC. J Pharmaceut Biomed Anal.
  11. Determination of synephrine in bitter orange raw materials, extracts, and dietary supplements by liquid chromatography with ultraviolet detection: single laboratory validation.
  12. (2011). Evidence (mostly negative) with the use of sympathomimetic agents for weight loss.
  13. (2006). Flavonoid composition of fruit tissues of Citrus species. Biosci Biotechnol.Biochem.
  14. (2010). Genetics of caffeine consumption and responses to coffee. Psychopharmacol.
  15. (2005). Hemodynamic effects of ephedra-free weight-loss supplements in humans.
  16. (2010). Hesperetin protects against oxidative stress related hepatic dysfunction by cadmium in rats. Exptl Toxicol Pathol
  17. High-pressure liquid chromatography methods for the analysis of adrenergic amines and flavanones
  18. Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exptl Toxicol.2010;
  19. (2008). Human pharmacology of a performance–enhancing dietary supplement under resting and exercise conditions. Brit J Clin Pharmacol.
  20. (2005). Increase in the thermic effect of food in women by adrenergic amines extracted from Citrus aurantium. Obesity Res.
  21. (2003). Lipid lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clin Chim Acta
  22. (2006). Media spins numbers on bitter orange AERs based on erroneous information from FDA. HerbalGram,
  23. (2006). Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males.
  24. (2008). Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate transcription of adiponectin. Phytother Res.
  25. (2009). Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet induced insulin resistance. Diabetes
  26. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression.
  27. (2007). Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care
  28. (2007). Pharmakokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects.
  29. (1999). Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl- CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids.
  30. (2001). Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following habitual diet, and diets high or low in fruit and vegetables.
  31. (2001). Plasma kinetics and urinary excretion of the flavonones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit
  32. (2010). Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats.
  33. Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet.
  34. (2004). Safety and efficacy of Citrus aurantium for weight loss.
  35. (2008). Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). J Agric.Food Chem.
  36. (2011). The cardiovascular effects of methylxanthines. Handb Exptl Pharmacol.
  37. (2010). The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des.
  38. (2011). The safety of bitter orange (Citrus aurantium) and p-synephrine. HerbalGram
  39. (2010). Trere T,et al. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements. J Sep Sci.